Literature DB >> 1356903

Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure.

M S Swain1, M Bergeron, R Audet, A T Blei, R F Butterworth.   

Abstract

Alterations of brain and cerebrospinal fluid amino acids have consistently been described in human and experimental fulminant liver failure. To evaluate the significance of such changes in the pathogenesis of hepatic encephalopathy in fulminant liver failure, brain and cerebrospinal fluid amino acids (glutamate, aspartate, GABA, glycine, taurine) were measured at various stages during the development of neurological dysfunction in rats after hepatic devascularization or thioacetamide treatment to induce acute liver failure. To facilitate repetitive removal of cerebrospinal fluid, a technique employing long-term implantation of cisterna magna catheters in conscious, freely moving rats was developed. Brain but not cerebrospinal fluid concentrations of the excitatory amino acids glutamate and aspartate were reduced in both animal models of fulminant liver failure in parallel with deterioration of neurological status. Brain and cerebrospinal fluid GABA levels were not significantly altered. Cerebrospinal fluid glycine levels were increased two to three times in parallel with increasing brain glycine content in the devascularized rat but were unchanged in thioacetamide-induced liver failure, suggesting distinct pathophysiological mechanisms in these two experimental situations. On the other hand, onset of coma in both animal models of fulminant liver failure was accompanied by significantly increased cerebrospinal fluid taurine levels. We suggest that such changes result from taurine release from astrocytes in brain into the extracellular fluid; this is consistent with taurine's role in the regulation of intracellular osmolarity in brain. Sequential measurements of amino acids in the cerebrospinal fluid of small rodents with indwelling cisterna magna catheters adds a useful new approach for exploring the neurobiology of hepatic encephalopathy in fulminant liver failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356903     DOI: 10.1002/hep.1840160428

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Mild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospects.

Authors:  Nicolas Chatauret; Christopher Rose; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Metab Brain Dis       Date:  1997-06       Impact factor: 3.584

Review 3.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

4.  Neuroactive amino acids in hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

5.  Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure.

Authors:  Anne Chastre; Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-03-10       Impact factor: 3.584

6.  (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

Authors:  Konstantinos John Dabos; John Andrew Parkinson; Ian Howard Sadler; John Nicholas Plevris; Peter Clive Hayes
Journal:  World J Hepatol       Date:  2015-06-28

7.  Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure.

Authors:  N Chatauret; C Rose; G Therrien; R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

8.  Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.

Authors:  R J de Knegt; J Kornhuber; S W Schalm; K Rusche; P Riederer; J Tan
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

9.  Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit.

Authors:  M Groeneweg; R J de Knegt; A Hamberger; M Ding; S Wang; S W Schalm; K G Haglid
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

10.  L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.

Authors:  C Rose; A Michalak; P Pannunzio; G Therrien; G Quack; G Kircheis; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.